TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05742646

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MATADORS
Description: Youth will have access to the MATADORS app to include basic information and expanded educational features. They will be asked to log into the app daily for one month and they will be asked to report within the app how they are feeling each day and their medications taken.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MATADORS Control
Description: Youth will have access to the MATADORS app basic information. They will be asked to log into the app daily for one month and they will be asked to report within the app their medications taken.
Study: NCT05978401

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLS-012+GLS-010+paclitaxel+carboplatin
Description: GLS-012+GLS-010 will be given via IV infusion on Day 1 of each 21-day cycle in combination with paclitaxel and carboplatin. Combination treatment will be administered 4\~6 cycles.GLS-012+GLS-010/GLS-010 may continue until disease progression or loss of clinical benefit.
Study: NCT06557967

Intervention type: OTHER
Intervention: No drug
Description: This is a non-interventional study and no study drug will be provided.

Intervention type: OTHER
Intervention: No drug
Description: This is a non-interventional study and no study drug will be provided.
Study: NCT05447104

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mastication
Description: Chewing sugar-free gum for 20 min
Study: NCT04884282

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tedopi
Description: TEDOPI is a T-specific immunotherapy was designed to induce cytotoxic T-lymphocytes against five five tumor associated antigens (ie CEA, p53, HER-2/neu, MAGE2 and MAGE3)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tedopi
Description: TEDOPI is a T-specific immunotherapy was designed to induce cytotoxic T-lymphocytes against five five tumor associated antigens (ie CEA, p53, HER-2/neu, MAGE2 and MAGE3)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab is a soluble protein consisting of 4 polypeptide chains, which include 2 identical heavy chains and 2 identical light chains. Nivolumab is produced from cell culture using a CHO cell line.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Docetaxel is a cytotoxic microtubule inhibiting antineoplastic agent in the taxane class. Docetaxel monotherapy is indicated for locally advanced or metastatic NSCLC after failure of prior platinum- based chemotherapy.

Intervention type: DRUG
Group type: OTHER
Intervention: Docetaxel
Description: Docetaxel is a cytotoxic microtubule inhibiting antineoplastic agent in the taxane class. Docetaxel monotherapy is indicated for locally advanced or metastatic NSCLC after failure of prior platinum- based chemotherapy.
Study: NCT05028322

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMIQUIMOD cream
Description: Cream to apply before intra-dermal vaccine injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HEPATITIS B SURFACE ANTIGEN
Description: HBV Vaccine

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: HEPATITIS B SURFACE ANTIGEN
Description: HBV Vaccine

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: HEPATITIS B SURFACE ANTIGEN
Description: HBV Vaccine
Study: NCT04745338

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 3max cool shaping device
Description: cryolipolysis sessions are applied on abdomen area each session for 40 min. each

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: low calolric diet
Description: low caloric diet (1200cal/day)

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: low calolric diet
Description: low caloric diet (1200cal/day)
Study: NCT06474637

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AEON Endoscopic Powered Stapler Handle and Reload
Description: The AEON™ Endoscopic Stapler places two triple-staggered rows of titanium staples while simultaneously transecting between the two triple-staggered rows of staples. The size of the staples and staple line length are based on the selection of the Stapler Reload (2.0mm, 2.5mm, 3.25mm, 4.0mm, 5.0mm and 5.5mm).
Study: NCT06557967

Intervention type: OTHER
Intervention: No drug
Description: This is a non-interventional study and no study drug will be provided.
Study: NCT05036317

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin (Jardiance®;
Description: Each tablet contains the active substance of 10 mg empagliflozin as well as the adjuvant lactose-monohydrate and is taken orally once daily in the morning.
Study: NCT05146999

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: QM1114-DP
Description: QM1114-DP
Study: NCT05447104

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mastication
Description: Chewing sugar-free gum for 20 min
Study: NCT06407739

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Three-Phase Physical Therapy Intervention
Description: Phase 1: It include subtalar and talocrural joint mobilization in the supine position along with stretching and home education Stage 2: It include subtalar and talocrural joint mobilization in the supine position along with Kinesiotaping and functional exercises Phase 3: this phase include balance and propioceptive training aling with along with strengthening exercises of peroneal and tibialis anterior
Study: NCT05146999

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06018376

Intervention type: DRUG
Intervention: Systemic oncological treatment
Description: Oncological systemic treatment for at least 3 months or being in oncological follow-up after having received systemic treatment for a minimum of 3 months
Study: NCT05261126

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enclitide Chloride
Description: Enclitide Chloride administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enclitide Chloride
Description: Enclitide Chloride administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enclitide Chloride
Description: Enclitide Chloride administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enclitide Chloride
Description: Enclitide Chloride administered orally

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo matching enclitide chloride administered orally
Study: NCT05156749

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: short-arm fiberglass cast
Description: fracture stabilization of salter harris I/II fractures with a fiberglass short-arm cast

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: long-arm fiberglass cast
Description: fracture stabilization of salter harris I/II fractures with a fiberglass long-arm cast
Study: NCT06495645

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI-assisted upper gastrointestinal endoscopy
Description: AI-assisted upper gastrointestinal endoscopy

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AI-assisted upper gastrointestinal endoscopy
Description: AI-assisted upper gastrointestinal endoscopy
Study: NCT06433271

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transdiagnostic Behavior Therapy (TBT)
Description: TBT manualized treatment incorporates daily exposure exercises from up to four categories of avoidance that are most characteristic of the emotional disorders (i.e., situational, interoceptive, imaginal, and positive emotional).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual-Problem Solving Therapy (TAU-PST)
Description: PST is an evidence- based psychotherapy implemented in VA Primary Care - Mental Health Integration (PC-MHI), with hundreds of VA providers trained in the intervention nationally. The primary aim of PST is to improve a patient's ability to cope with stressful events by adopting an adaptive perspective to stressors and using goal-focused, problem-solving behaviors to manage the problems associated with the stressors.
Study: NCT06546709

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LASSARAB+ aPHAD-SEat 700rU
Description: Rabies-Vectored Monovalent Lassa Fever Vaccine (LASSARAB) with 3D-(6- acyl) Phosphorylated Hexaacyl Disaccharides (PHAD)-Stable squalene oil-in-water nanoemulsion (aPHAD-SE) adjuvant administered by IM injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LASSARAB+ aPHAD-SEat 700rU
Description: Rabies-Vectored Monovalent Lassa Fever Vaccine (LASSARAB) with 3D-(6- acyl) Phosphorylated Hexaacyl Disaccharides (PHAD)-Stable squalene oil-in-water nanoemulsion (aPHAD-SE) adjuvant administered by IM injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HDCV Comparator
Description: Sterile, stable, freeze-dried suspension of rabies virus prepared from strain PM-1503-3M

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HDCV Comparator
Description: Sterile, stable, freeze-dried suspension of rabies virus prepared from strain PM-1503-3M

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HDCV Comparator
Description: Sterile, stable, freeze-dried suspension of rabies virus prepared from strain PM-1503-3M

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HDCV Comparator
Description: Sterile, stable, freeze-dried suspension of rabies virus prepared from strain PM-1503-3M

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Normal Saline Placebo
Description: Sterile 0.9% sodium chloride for injection, USP, or normal saline, is a sterile, nonpyrogenic, isotonic solution; each mL contains sodium chloride 9 mg

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Normal Saline Placebo
Description: Sterile 0.9% sodium chloride for injection, USP, or normal saline, is a sterile, nonpyrogenic, isotonic solution; each mL contains sodium chloride 9 mg

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LASSARAB+ aPHAD-SEat 1400rU
Description: Rabies-Vectored Monovalent Lassa Fever Vaccine (LASSARAB) with 3D-(6- acyl) Phosphorylated Hexaacyl Disaccharides (PHAD)-Stable squalene oil-in-water nanoemulsion (aPHAD-SE) adjuvant administered by IM injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LASSARAB+ aPHAD-SEat 1400rU
Description: Rabies-Vectored Monovalent Lassa Fever Vaccine (LASSARAB) with 3D-(6- acyl) Phosphorylated Hexaacyl Disaccharides (PHAD)-Stable squalene oil-in-water nanoemulsion (aPHAD-SE) adjuvant administered by IM injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LASSARAB+ aPHAD-SEat 1400rU
Description: Rabies-Vectored Monovalent Lassa Fever Vaccine (LASSARAB) with 3D-(6- acyl) Phosphorylated Hexaacyl Disaccharides (PHAD)-Stable squalene oil-in-water nanoemulsion (aPHAD-SE) adjuvant administered by IM injection
Study: NCT05267652

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Preoxygenation with Non-Invasive Positive Pressure Ventilation
Description: The delivery of oxygen and ventilation by non-invasive mechanical ventilation via a tight-fitting mask from the initiation of preoxygenation until the initiation of laryngoscopy. Trial protocol will not dictate the brand or type of mechanical ventilator that will be used to deliver non-invasive ventilation.
Study: NCT05036317

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Intervention
Description: Placebo will be provided by Boehringer Ingelheim. It is identical to the interventional product apart from the active compound.
Study: NCT06011837

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Altered Auditory Feedback
Description: Mumble Melody is an application that leverages Altered Auditory Feedback (AAF). During AAF, a person's speech is altered in near-real time. Mumble Melody modulates the user's voice and plays it back to them while they are speaking. Included are Unaltered (raw voice), Whisper (voiceless sound), Reverb (cathedral sound), and Harmonized (robotic sound) voice transformations.
Study: NCT06206018

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PROM_R knee rehabilitation program
Description: The rehabilitation program consists of 5 weekly sessions for 4 weeks, supervised by a specialized physiotherapist at every session.~All patients follow the same order of treatment and exercises, starting with massage and mobilization, followed by the corresponding exercise program, and ending with Neuromuscular Electrical Stimulation (NMES) and cryotherapy.
Study: NCT05668286

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: A combination of 1 mL of triamcinolone acetonide (40 mg/mL) and 1 mL of prilocaine hydrochloride (2%)
Description: patients in group 1 received an anterior extra-articular steroid injection under USG guidance, patients in group 2 received posterior intra-articular steroid injection under USG guidance. A combination of 1 mL of triamcinolone acetonide (40 mg/mL) and 1 mL of prilocaine hydrochloride (2%) were injected to all patients.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: A combination of 1 mL of triamcinolone acetonide (40 mg/mL) and 1 mL of prilocaine hydrochloride (2%)
Description: patients in group 1 received an anterior extra-articular steroid injection under USG guidance, patients in group 2 received posterior intra-articular steroid injection under USG guidance. A combination of 1 mL of triamcinolone acetonide (40 mg/mL) and 1 mL of prilocaine hydrochloride (2%) were injected to all patients.
Study: NCT06018623

Intervention type: OTHER
Intervention: It is an observational study and no non-routine procedures will be performed on patients. Routine anesthesia procedure will be applied to the patients
Description: It is an observational study and no non-routine procedures will be performed on patients.~Routine anesthesia procedure will be applied to the patients

Intervention type: OTHER
Intervention: It is an observational study and no non-routine procedures will be performed on patients. Routine anesthesia procedure will be applied to the patients
Description: It is an observational study and no non-routine procedures will be performed on patients.~Routine anesthesia procedure will be applied to the patients

Intervention type: OTHER
Intervention: It is an observational study and no non-routine procedures will be performed on patients. Routine anesthesia procedure will be applied to the patients
Description: It is an observational study and no non-routine procedures will be performed on patients.~Routine anesthesia procedure will be applied to the patients
Study: NCT05938803

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PASEO
Description: The intervention consists of community-based accompaniment intervention aimed at facilitating the transition to adult HIV care for adolescents living with HIV in Lima, Peru.The intervention includes the following activities: health systems navigation and accompaniment to clinic visits, monthly check-ins with an entry-level health worker, social support provided through peer support groups, education sessions, resolution of acute needs, and individualized adherence support.
Study: NCT01637155

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Description: One baseline oral dose of 50.000 UI to determine pharmacokinetics. After 28 days, patients take a period of 90 days of standardization of cholecalciferol based on baseline levels. After this period, patients receive a second oral dose of 50.000 UI to determine a second pharmacokinetics.
Study: NCT06319534

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comprehensive rehabilitation
Description: All the participants are provided with the comprehensive rehabilitation (routine rehabilitation and swallowing function training). The routine rehabilitation included intervention for risk factors (blood pressure, blood lipids, blood glucose, smoking and alcohol restriction, exercise, etc.).

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Comprehensive rehabilitation
Description: All the participants are provided with the comprehensive rehabilitation (routine rehabilitation and swallowing function training). The routine rehabilitation included intervention for risk factors (blood pressure, blood lipids, blood glucose, smoking and alcohol restriction, exercise, etc.).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stellate ganglion block
Description: The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study: NCT05377372

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breastfeeding support group
Description: community-based breastfeeding support group aimed to increase exclusive breastfeeding success rates among Black women

Intervention type: OTHER
Group type: OTHER
Intervention: Observation
Description: Observe prospectively for breastfeeding initiation, duration and longitudinal health of child with sickle cell disease
Study: NCT04165213

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Care of Older Persons in their Environment (COPE) online module training
Description: An online module version of training for clinicians (OTs and RNs) in the evidence-based dementia caregiving program called Care of Older Persons in their Environment (COPE) is the intervention being tested for non-inferiority against the usual instructor-led COPE training. COPE modules include rich multimedia content, simulated scenarios, interactive assessments to keep the learner engaged The content is packaged into the latest the latest Shareable Content Object Reference Model (SCORM) specifications, which will allow for repurposing and sharing with other institutions. Each of the ten modules last 45-60 minutes.
Study: NCT06319534

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: the patients are provided with Stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study: NCT05267652

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Facemask Oxygen
Description: The delivery of supplemental oxygen via a non-rebreather mask or bag-mask device without manual ventilation from the initiation of preoxygenation until induction. Trial protocol will not dictate the brand or type of facemask. The decision between use of a non-rebreather mask and use of a bag-mask device will be made by treating clinicians. The decision of whether to provide manual ventilation with a bag-mask device between induction and laryngoscopy will be made by treating clinicians.
Study: NCT04165213

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Care of Older Persons in their Environment (COPE) online module training
Description: An online module version of training for clinicians (OTs and RNs) in the evidence-based dementia caregiving program called Care of Older Persons in their Environment (COPE) is the intervention being tested for non-inferiority against the usual instructor-led COPE training. COPE modules include rich multimedia content, simulated scenarios, interactive assessments to keep the learner engaged The content is packaged into the latest the latest Shareable Content Object Reference Model (SCORM) specifications, which will allow for repurposing and sharing with other institutions. Each of the ten modules last 45-60 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Care of Older Persons in their Environment (COPE) online module training
Description: An online module version of training for clinicians (OTs and RNs) in the evidence-based dementia caregiving program called Care of Older Persons in their Environment (COPE) is the intervention being tested for non-inferiority against the usual instructor-led COPE training. COPE modules include rich multimedia content, simulated scenarios, interactive assessments to keep the learner engaged The content is packaged into the latest the latest Shareable Content Object Reference Model (SCORM) specifications, which will allow for repurposing and sharing with other institutions. Each of the ten modules last 45-60 minutes.
Study: NCT05935306

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: All participants will undergo the same conventional surgical procedure. Patients will receive the FBM simulation and will be treated identically to the G2 group.
Study: NCT06142032

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Metaverse support group
Description: Delivery method: Online, virtual platforms. Number of sessions: 5. Duration of each session: 1.5 hours. Sessions will adhere to evidence-based protocols for conducting support groups with a trauma-informed approach. Each session will cover a specific topic of interest related to the challenges faced by Ukrainian refugees (e.g., stress management, cultural adjustment, self-care, etc.).~Support group session structure:~* Introduction, check-in, ground rules;~* Introducing the topic (topics will be chosen based on the feedback received from a previous session; the first session will cover a topic chosen by the facilitator);~* Encouragement of participants to share thoughts, ideas and experiences;~* Psychoeducation on the topics;~* Summary, takeaway, feedback.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: In-Person support group
Description: Delivery method: In-Person, traditional. Number of sessions: 5. Duration of each session: 1.5 hours. Sessions will adhere to evidence-based protocols for conducting support groups with a trauma-informed approach. Each session will cover a specific topic of interest related to the challenges faced by Ukrainian refugees (e.g., stress management, cultural adjustment, self-care, etc.).~Support group session structure:~* Introduction, check-in, ground rules;~* Introducing the topic (topics will be chosen based on the feedback received from a previous session; the first session will cover a topic chosen by the facilitator);~* Encouragement of participants to share thoughts, ideas and experiences;~* Psychoeducation on the topics;~* Summary, takeaway, feedback.